HBW
ZBH icon

Hazlett, Burt & Watson’s Zimmer Biomet ZBH Stock Holding History

Hazlett, Burt & Watson’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65K Buy
755
+200
+36% +$17.5K 0.02% 420
2026
Q1 		$50K Hold
555
– – 0.02% 452
2025
Q4 		$49K Hold
555
– – 0.02% 449
2025
Q3 		$55K Sell
555
-50
-8% -$4.96K 0.02% 405
2025
Q2 		$55K Sell
605
-156
-20% -$15.1K 0.02% 361
2025
Q1 		$87K Sell
761
-54
-7% -$5.78K 0.04% 289
2024
Q4 		$85K Buy
815
+156
+24% +$16.7K 0.04% 295
2024
Q3 		$70K Sell
659
-90
-12% -$9.82K 0.03% 313
2024
Q2 		$81K Hold
749
– – 0.04% 285
2024
Q1 		$99K Buy
749
+54
+8% +$6.75K 0.06% 247
2023
Q4 		$84K Hold
695
– – 0.06% 241
2023
Q3 		$79K Hold
695
– – 0.06% 250
2023
Q2 		$101K Hold
695
– – 0.08% 211
2023
Q1 		$90K Buy
695
+60
+9% +$7.53K 0.07% 207
2022
Q4 		$81K Hold
635
– – 0.07% 213
2022
Q3 		$66K Hold
635
– – 0.06% 235
2022
Q2 		$66K Hold
635
– – 0.06% 240
2022
Q1 		$82K Buy
+635
New +$76.5K 0.07% 229

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hazlett, Burt & Watson's ZBH Position: Q2 2026 in Review

Hazlett, Burt & Watson increased its Zimmer Biomet (ZBH) stake by 36% in Q2 2026, buying an estimated $17.5K and bringing the position to 755 shares worth $65K. The position accounts for 0.02% of the portfolio, ranked #420.

Hazlett, Burt & Watson first reported a position in ZBH in Q1 2022 and has held it in 18 quarters since. The position peaked at $101K in Q2 2023. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Hazlett, Burt & Watson held 755 shares of Zimmer Biomet worth $65K as of Q2 2026.
  • Hazlett, Burt & Watson bought 200 Zimmer Biomet shares in Q2 2026, an estimated $17.5K.
  • Zimmer Biomet made up 0.02% of Hazlett, Burt & Watson's portfolio in Q2 2026, its #420 holding.
  • Hazlett, Burt & Watson first reported a position in Zimmer Biomet in Q1 2022 and has held it in 18 quarters since.
  • Hazlett, Burt & Watson's Zimmer Biomet position peaked at $101K in Q2 2023.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.